share_log

Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition

Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition

迷幻公司Core One Labs斥資300萬美元新收購功能性蘑菇
Benzinga Real-time News ·  2021/12/27 13:06

Psychedelics company Core One Labs Inc. (CSE:COOL) (OTC:CLABF) is expanding into the functional mushroom space with the acquisition of New Path Laboratories Inc., a British Columbia-based company dedicated to the development and licensing of natural health products and dietary supplements.

迷幻藥公司Core One Labs Inc.(CSE：COOL)(場外交易代碼：CLABF)通過收購新路徑實驗室公司一家總部位於不列顛哥倫比亞省的公司，致力於天然保健品和膳食補充劑的開發和許可。

"This acquisition further extends the company's presence in the functional mushrooms space and also will allow the company to generate sales revenue by virtue of adding retail distribution channels to its business model and reach an exponentially growing consumer base," said Joel Shacker, CEO Core One Labs.

“此次收購進一步擴大了公司在功能性蘑菇領域的地位，還將使公司通過在其業務模式中增加零售分銷渠道來創造銷售收入，並接觸到呈指數級增長的消費者基礎，”他説。喬爾·謝克首席執行官Core One實驗室。

New Path incorporates functional mushrooms to help support everyday biological functions in the maintenance of good health and has a vertical integration model that can allow it to grow, develop and distribute natural health products and dietary supplements from spore to sale. 

New Path結合了功能性蘑菇，以幫助支持維持健康的日常生物功能，並具有垂直整合模式，使其能夠從孢子到銷售種植、開發和分銷天然保健品和膳食補充劑。

Core One has purchased New Path through an all-stock transaction of 5,700,000 common shares, valued at approximately CA$3.9 million ($3 million).

Core One通過570萬股普通股的全股票交易收購了New Path，價值約390萬加元(300萬美元)。

Core One over-the-counter shares were $0.44 at the time of this writing.

在撰寫本文時，Core One的場外股票為0.44美元。

Photo by Kalineri on Unsplash.

照片由卡萊尼在Unspash上拍攝。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論